Editorial: Novel Treatments for Cardiovascular Diseases by Targeting Inflammation, Oxidative Stress, and Cell Death

Overview

Journal Front Cardiovasc Med

Date 2025 Jan 23

PMID 39844902

Authors

Dong Fan

Li Wang

Abhijit Chakraborty

Cheng-Lin Zhang

Feng Hua Yang

Affiliations

Soon will be listed here.

References

Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G . Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021; 7(1):193. PMC: 8313570. DOI: 10.1038/s41420-021-00579-w. View

Ridker P, MacFadyen J, Everett B, Libby P, Thuren T, Glynn R . Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2017; 391(10118):319-328. DOI: 10.1016/S0140-6736(17)32814-3. View

Hiraiwa H, Kasugai D, Okumura T, Murohara T . Clinical implications of septic cardiomyopathy: A narrative review. Medicine (Baltimore). 2024; 103(17):e37940. PMC: 11049701. DOI: 10.1097/MD.0000000000037940. View

Greenberg H, Zhao G, Shah A, Zhang M . Role of oxidative stress in calcific aortic valve disease and its therapeutic implications. Cardiovasc Res. 2021; 118(6):1433-1451. PMC: 9074995. DOI: 10.1093/cvr/cvab142. View

Wang S, Zhang K, Huang Q, Meng F, Deng S . TLR4 signalling in ischemia/reperfusion injury: a promising target for linking inflammation, oxidative stress and programmed cell death to improve organ transplantation outcomes. Front Immunol. 2024; 15:1447060. PMC: 11291251. DOI: 10.3389/fimmu.2024.1447060. View

Shi P, Sha Y, Wang X, Yang T, Wu J, Zhou J . Targeted Delivery and ROS-Responsive Release of Lutein Nanoassemblies Inhibit Myocardial Ischemia-Reperfusion Injury by Improving Mitochondrial Function. Int J Nanomedicine. 2024; 19:11973-11996. PMC: 11585303. DOI: 10.2147/IJN.S488532. View

Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J . Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024; 9(1):12. PMC: 10772178. DOI: 10.1038/s41392-023-01688-x. View

Davidson S, Ferdinandy P, Andreadou I, Botker H, Heusch G, Ibanez B . Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(1):89-99. DOI: 10.1016/j.jacc.2018.09.086. View

Palasubramaniam J, Wang X, Peter K . Myocardial Infarction-From Atherosclerosis to Thrombosis. Arterioscler Thromb Vasc Biol. 2019; 39(8):e176-e185. DOI: 10.1161/ATVBAHA.119.312578. View

10.

Ridker P, Everett B, Thuren T, MacFadyen J, Chang W, Ballantyne C . Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; 377(12):1119-1131. DOI: 10.1056/NEJMoa1707914. View

11.

Martin S, Aday A, Almarzooq Z, Anderson C, Arora P, Avery C . 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024; 149(8):e347-e913. DOI: 10.1161/CIR.0000000000001209. View

12.

Dhalla N, Shah A, Adameova A, Bartekova M . Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury. Biomedicines. 2022; 10(7). PMC: 9313001. DOI: 10.3390/biomedicines10071473. View

13.

Carbone F, Liberale L, Preda A, Schindler T, Montecucco F . Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting. Cells. 2022; 11(18). PMC: 9496713. DOI: 10.3390/cells11182833. View

14.

Hollenberg S, Singer M . Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021; 18(6):424-434. DOI: 10.1038/s41569-020-00492-2. View

15.

Zheng W, Chan W, Dart A, Shaw J . Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease. Eur Heart J Cardiovasc Pharmacother. 2023; 10(1):53-67. DOI: 10.1093/ehjcvp/pvad074. View

16.

Punnanithinont N, Kambalapalli S, Iskander B, Ichikawa K, Krishnan S, Lakshmanan S . "Anti-inflammatory Therapies in Atherosclerosis - Where are we going?". Curr Atheroscler Rep. 2024; 27(1):19. DOI: 10.1007/s11883-024-01267-7. View

17.

Hafiane A, Pisaturo A, Favari E, Bortnick A . Atherosclerosis, calcific aortic valve disease and mitral annular calcification: same or different?. Int J Cardiol. 2024; 420:132741. DOI: 10.1016/j.ijcard.2024.132741. View

18.

Fan D, Wu R . Mechanisms of the septic heart: From inflammatory response to myocardial edema. J Mol Cell Cardiol. 2024; 195:73-82. DOI: 10.1016/j.yjmcc.2024.08.003. View